Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia
Clinical trial NCT05632484 · COMPLETED
Trial details
- NCT number
- NCT05632484
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-05-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.